This transcription factor plays a key role in pancreatic beta cell function, so mutations in TCF1 cause autosomal dominant maturity-onset diabetes of the young type 3 (MODY3) and hyperinsulinemic hypoglycemia. Some mutations are also associated with renal dysplasia and hypopituitarism.
MODY 3 Diabetes is one of the most common types of MODY. About 10% of MODY in Germany is caused by mutations of this transcription factor. These mutations could be found worldwide.
The gene also known as hepatic nuclear factor is now called TCF1. Locus is on chromosome 12 (12q24.2). Size is about 24kb. Is consists of 12 Exons. 10 of them are translated.
Mutations in this gene are responsible for autosomal dominant MODY 3 diabetes. Biochemically the picture is similar to type 2 diabetes but manifestation is early in life and there is no metabolic syndrome. In contrast to MODY 2 diabetes this type of MODY is progressive. Over the time Patients require insulin therapy and develop diabetic injuries The diabetes becomes apparent in situations of metabolic stress i.e. in pregnancy or during medication with glucocorticoids.
The protein product of this gene is a transcription factor involved in the regulation of many different genes. The exact mechanism leading to diabetes is not known.
Patients with family history and laboratory data suspect for MODY diabetes. Screening of family member in a known MODY family.
The detection of a mutation in this gene is a prerequisite for the diagnosis.
| Clinic | Method | Carrier testing |
| Turnaround | 5 days | |
| Specimen type | genomic DNA |
| Clinic | Method | Massive parallel sequencing |
| Turnaround | 25 days | |
| Specimen type | genomic DNA |
| Clinic | Method | Genomic sequencing of the entire coding region |
| Turnaround | 20 days | |
| Specimen type | genomic DNA |
| Clinic | Method | Multiplex Ligation-Dependent Probe Amplification |
| Turnaround | 20 days | |
| Specimen type | genomic DNA |